ReviewTherapeutic advances in musculoskeletal disease2026
Towards an individualised approach to pain management in inflammatory arthritis.
Review in Therapeutic advances in musculoskeletal disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pain management in inflammatory arthritis (IA) remains challenging. The contribution of multiple mechanistic factors to the initiation and maintenance of pain, and the interplay of sensory, psychological and social factors that modulate perceptual outcomes, requires a multi-faceted approach that does not solely rely on inflammation-targeted therapies. Growing evidence points to the contribution of, and therefore the need to target, centrally mediated pain processes and/or peripheral sensitisation not associated with inflammatory burden. In this review, we examine current evidence on the mechanistic underpinnings of pain in both early and established IA, including novel insights regarding the manifestation of peripherally and centrally mediated pain. Further, we discuss evolving terminology used to describe pain types, including implications for clinical assessment and communication. Finally, we consider how treatment strategies - pharmacological and non-pharmacological - could fit into an individualised approach, exploring barriers to implementation in clinical practice, including limitations in pain assessment and practical challenges in service delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.